✦ LIBER ✦

Alzheimer's disease: Pharmacological developments to the year 2000

✍ Scribed by Alistair Burns

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 401 KB
Volume: 10
Category: Article
ISSN: 0885-6222
DOI: 10.1002/hup.470101009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Burden of disease related to Parkinson's

Burden of disease related to Parkinson's disease in Spain in the year 2000

✍ Esther Cubo; Elena Alvarez; Consuelo Morant; Jesús De Pedro Cuesta; Pablo Martín 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

## Abstract We measured the burden caused by Parkinson's disease (PD) in Spain during the year 2000 and compared it against PD burden worldwide and in the European A subregion. Burden of disease (BoD) is an important factor in health policy. Disability‐adjusted life years (DALY) as a measure of BoD

The economic consequences of Alzheimer's

The economic consequences of Alzheimer's disease in the context of new drug developments

✍ Martin Knapp; David Wilkinson; Rachel Wigglesworth 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 3 views

The first national symptomatic treatment for Alzheimer's disease has received a very mixed and perhaps ageist reception from purchasers of health care in the UK. This is largely because detailed information on the long-term effects of this class of drugs is scarce. However, by looking at the publish

Pharmacologic approaches to the treatmen

Pharmacologic approaches to the treatment of Huntington's disease

✍ Charles S. Venuto; Andrew McGarry; Qing Ma; Karl Kieburtz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract Huntington's disease (HD) is an inherited, progressive neurodegenerative disorder characterized by chorea, cognitive impairment, and behavioral disturbances. Despite advances in diagnosis and improved understanding of HD, treatment remains difficult due to challenging symptoms and a pau

CEC: Selected developments that caught m

CEC: Selected developments that caught my eye since the year 2000

✍ Frantisek Svec 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

## Abstract During the last decade, a number of new developments have emerged in the field of CEC. This paper focuses only on monolithic columns prepared from synthetic polymers. Monolithic columns have become a well‐established format of stationary phases for CEC immediately after their inception

Translational medicine perspective in de

Translational medicine perspective in development of disease modifying therapies for Alzheimer's disease: biomarkers to buy down the risk

✍ Hong I. Wan; Orest Hurko; Mark Day; J. Lynn Rutkowski 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

Characteristics of elderly who develop A

Characteristics of elderly who develop Alzheimer's disease during the next two years—a neuropsychological study using CAMCOG. The Odense study

✍ Henry Nielsen; Annette Lolk; Kjeld Andersen; Jutta Andersen; Per Kragh-Sørensen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Objective. The aim of the study was to determine which cognitive functions ®rst deteriorate in Alzheimer's disease (AD) and to identify persons who would become demented 2 years following an initial examination. Participants. A total of 2452 initially non-demented persons, aged 65±84 years and rand